New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:03 EDTKND, GTIVKindred says disappointed, but not deterred, by Gentiva 'poison pill'
Kindred Healthcare (KND) announded it sent a letter to the Gentiva Health (GTIV) Board of Directors in response to the poison pill, also known as a “shareholder rights plan,” implemented by the Gentiva Board and disclosed by Gentiva on Friday, May 23. In the letter, Kindred stated in part: "Since the May 15, 2014 public announcement of our offer to acquire Gentiva for total consideration of $14.00 per share, we have heard from both companies’ shareholders – and sell-side research analysts have reported – that they support a combination and that the price is a very compelling and significant premium to Gentiva’s historic trading price and projected earnings estimates. We are certain you have heard the same from your shareholders. We are disappointed, however, that instead of listening to your shareholders – the true owners of Gentiva – and immediately entering into good faith negotiations with Kindred, your Board has instead implemented a poison pill that limits shareholders’ opportunity to maximize the value of their investment. We question the motive and timing of such implementation, which limits not just Kindred, but all Gentiva shareholders from increasing their investment in the company...Despite Gentiva’s actions, we will not be deterred. We are determined to pursue the proposed combination of Kindred and Gentiva and are committed over the long-term to achieving our objective. We are ready, willing and able to quickly proceed toward consummating a negotiated transaction."
News For KND;GTIV From The Last 14 Days
Check below for free stories on KND;GTIV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
10:25 EDTKND, GTIVGentiva Health not in talks with Kindred Healthcare, says dealReporter
According to contacts, dealReporter said Gentiva Health (GTIV) and Kindred Healthcare (KND) have not had any discussions, contradicting recent rumors.
July 21, 2014
19:12 EDTKND, GTIVGentiva Health announces receipt of acquisition proposal from Kindred Healthcare
Subscribe for More Information
17:40 EDTKND, GTIVKindred Healthcare offers to acquire Gentiva Health for $17.25 per share
Subscribe for More Information
17:32 EDTKND, GTIVKindred Healthcare offers to acquire Gentiva Health for $17.25 per share
Subscribe for More Information
July 18, 2014
16:20 EDTKND, GTIVOn The Fly: Closing Wrap
Subscribe for More Information
12:42 EDTKND, GTIVOn The Fly: Midday Wrap
Stocks on Wall Street began the session in positive territory and have remained there throughout the morning. The averages moved in a narrow range for most of the opening hour of the session but spurted to higher levels during the second hour. Investors appear to be using yesterday’s sell-off as a buying opportunity, despite the ongoing events in Russia and Israel that largely contributed to yesterday’s action. ECONOMIC EVENTS: The first release of the University of Michigan consumer sentiment index for July fell to 81.3 after ending June with an 82.5 reading. The leading economic indicator index rose 0.3% to 102.2, which was a bit below the forecast for an increase of 0.5%. COMPANY NEWS: Class A shares of Google (GOOGL) advanced over 3% after the search giant reported quarterly revenue that beat expectations last night. Following its report, at least three Wall Street research firms raised their price targets on the stock, while noted tech analyst Collin Gillis of BGC Financial upgraded the stock to Buy from Hold... Dow component General Electric (GE) reported second quarter EPS of 39c, matching the consensus forecast, and revenue that just missed the consensus view of analysts. The company also reported that it is targeting the initial public offering of IPO of Synchrony Financial (SYF), its North American Retail Finance business, for July. In the IPO, Synchrony is offering 125M shares of its common stock, which will be listed on the New York Stock Exchange under the symbol “SYF,” and anticipates that the IPO price of the shares will be between $23.00 and $26.00 per share... Another Dow member, IBM (IBM), fell 0.4% after reporting adjusted Q2 earnings per share and revenue that beat expectations. Afterward, Cantor said it thinks the worst is over for the company and reiterated its Buy rating on the shares, though Societe Generale downgraded IBM to Sell from Hold and Credit Suisse said IBM continues to be driven by less revenue growth and kept its Underperform rating and $160 price target on Big Blue's stock. MAJOR MOVERS: Among the notable gainers was Skyworks (SWKS), which gained 14% after reporting third quarter results and fourth quarter guidance above analyst estimates and seeing no less than five analyst firms raise their price targets on its stock. Also higher was Gentiva Health (GTIV), which rose 14% after it announced that its board unanimously determined to reject the partial tender offer from Kindred Healthcare (KND) to acquire 14.9% of the outstanding shares of Gentiva for a price of $16.00 per share in cash and disclosed that it has received a $17.25 per share, all-cash takeover proposal from a "recognized owner, operator and investor in the sector." After the announcement, shares of Kindred fell 2%. Also lower following their earnings reports were RealPage (RP), which fell over 21%, and Advanced Micro Devices (AMD), which dropped nearly 18%. INDEXES: Near midday, the Dow was up 107.05, or 0.63%, to 17,083.86, the Nasdaq was up 57.98, or 1.33%, to 4,421.43, and the S&P 500 was up 17.04, or 0.87%, to 1,975.16.
July 17, 2014
18:31 EDTGTIVOn The Fly: After Hours Movers
Subscribe for More Information
16:43 EDTGTIVGentiva Health up 11.5% after disclosing receipt of $17.25 takeover offer
Subscribe for More Information
16:42 EDTKND, GTIVGentiva says received $17.25 all-cash takeover bid, rejected Kindred $16 offer
Subscribe for More Information
16:36 EDTGTIV, KNDGentiva Health rejects prior Kindred Healthcare proposal, receives alternate bid
Subscribe for More Information
July 14, 2014
12:06 EDTGTIV, KNDGentiva Health urges holders to take no action in response to Kindred offer
Subscribe for More Information
09:55 EDTGTIVHigh option volume stocks: PTEN MFRM GTIV SHPG IMMR
07:32 EDTKND, GTIVKindred Healthcare increases all-cash tender offer for Gentiva to $16 per share
Subscribe for More Information
07:32 EDTKND, GTIVKindred Healthcare increases all-cash tender offer for Gentiva to $16 per share
Subscribe for More Information
July 9, 2014
08:21 EDTGTIVGentiva Health sees FY14 EPS 85c-$1.15, consensus 90c
Gentiva reaffirmed its full-year 2014 outlook. Net revenues are expected to be in the range of $1.9B-$2.1B, Adjusted EBITDA is expected to be in the range of $177M-$195M. FY14 revenue consensus $1.97B. Gentiva's 2014 outlook includes the full-year impact of its Harden acquisition and the final 2014 Medicare home health and hospice reimbursement rates issued by the Centers for Medicare and Medicaid Services (CMS). The 2014 outlook excludes any ongoing losses from closed locations as the operations are wound down.
08:19 EDTGTIVGentiva Health sees Q2 adjusted EPS from cont. ops 33c, consensus 22c
Gentiva Health said the company anticipates results from continuing operations for Q2 to be equal to or in excess of the following, net revenues of $496M, adjusted EBITDA of $52M. Q2 revenue consensus $492.46M. The company said, "Gentiva’s continued momentum in the second quarter of 2014 reflects the success of the changes and strategic investments the Company has made over the past year. We strongly believe that today’s announcement provides further evidence that Gentiva’s strategy to increase stockholder value is working, reinforcing that Kindred’s offer grossly undervalues Gentiva and is not in the best interest of Gentiva stockholders.”
08:17 EDTKND, GTIVGentiva Health says Kindred Healthcare offer 'substantially undervalues' company
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use